Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

por Chong, Dawn Q, Toh, Xin Y, Ho, Ivy AW, Sia, Kian C, Newman, Jennifer P, Yulyana, Yulyana, Ng, Wai-Hoe, Lai, Siang H, Ho, Mac MF, Dinesh, Nivedh, Tham, Chee K, Lam, Paula YP
Publicado 2015